Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Africa, African, agent, antigen, antitrust, Asia, Asian, Barcelona, beneficial, billion, borne, calendar, CanProbe, characterization, colorectal, Consortium, country, customary, depression, description, digit, double, EANM, East, entirety, EOY, ESMO, esophageal, EU, factor, FDA, fifty, Food, guided, hereto, inflationary, labor, median, melanoma, membrane, Middle, mitigate, monetary, NDA, Network, nonrefundable, notably, Octreotate, pancreatic, percentage, poster, pressure, Probe, promising, protein, PSMA, published, purport, recession, rest, RLT, satisfaction, satisfied, single, soft, Spain, structure, Sublicensee, sublicensor, submission, therapeutic, tissue, toxicity, underwritten, weakening
Removed:
meeting, society, source
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view